• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

反相高效液相色谱法和反相超高效液相色谱法用于测定含间甲酚药用产品中甲状旁腺激素(1-34)的方法开发与验证

Development and validation of RP-HPLC and RP-UPLC methods for quantification of parathyroid hormones (1-34) in medicinal product formulated with meta-cresol.

作者信息

Rane Shaligram S, Ajameri Alkesh, Mody Rustom, Padmaja P

机构信息

Department of Applied Chemistry, Faculty of Technology and Engineering, The Maharaja Sayajirao University of Baroda, Vadodara, Gujarat, India.

Intas Biopharmaceuticals Ltd., Ahmedabad, India.

出版信息

J Pharm Anal. 2012 Apr;2(2):136-142. doi: 10.1016/j.jpha.2011.12.001. Epub 2011 Dec 30.

DOI:10.1016/j.jpha.2011.12.001
PMID:29403733
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5760891/
Abstract

Rapid and sensitive reversed phase high performance liquid chromatography (RP-HPLC) and ultra performance liquid chromatography (RP-UPLC) method with UV detection has been developed and validated for quantification of parathyroid hormone (PTH) in presence of meta-cresol as a stabilizer in a pharmaceutical formulation. Chromatography was performed with mobile phase containing 0.1% Trifluoroacetic acid (TFA) in MilliQ water and 0.1% TFA in acetonitrile with gradient program and flow rate at 0.3 mL/min for HPLC and 0.4 mL/min for UPLC. Quantification was accomplished with internal reference standard (qualified against innovator product and National Institute for Biological Standards and Control (NIBSC) standard). The methods were validated for linearity (correlation coefficient=0.99), range, accuracy, precision and robustness. Robustness was confirmed by considering three factors; mobile phase composition, column temperature and flow rate/age of mobile phase. Intermediate precision was confirmed on different equipments, different columns and on different days. The relative standard deviation (RSD) (<2% for RP-HPLC and <1% for UPLC, =30) indicated a good precision. Retention time was found about 17 min and 2 min by HPLC and UPLC methods, respectively. Both methods are simple, highly sensitive, precise and accurate and have the potential of being useful for routine quality control.

摘要

已开发并验证了一种采用紫外检测的快速灵敏反相高效液相色谱法(RP-HPLC)和超高效液相色谱法(RP-UPLC),用于定量测定药物制剂中作为稳定剂的间甲酚存在下的甲状旁腺激素(PTH)。使用含有0.1%三氟乙酸(TFA)的超纯水和含有0.1% TFA的乙腈作为流动相,通过梯度程序进行色谱分析,HPLC的流速为0.3 mL/min,UPLC的流速为0.4 mL/min。采用内参标准品(与创新产品和国家生物标准与控制研究所(NIBSC)标准进行比对)进行定量。对方法的线性(相关系数 = 0.99)、范围、准确度、精密度和稳健性进行了验证。通过考虑三个因素确认了稳健性;流动相组成、柱温以及流动相的流速/使用时长。在不同设备、不同色谱柱以及不同日期确认了中间精密度。相对标准偏差(RSD)(RP-HPLC < 2%,UPLC < 1%,n = 30)表明精密度良好。通过HPLC和UPLC方法分别测得保留时间约为17分钟和2分钟。两种方法均简单、高度灵敏、精确且准确,具有用于常规质量控制的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e4d/5760891/70385df92963/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e4d/5760891/08aa29a59352/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e4d/5760891/9c16418c49bf/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e4d/5760891/3b26e93adb6d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e4d/5760891/e18cff5f87da/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e4d/5760891/f05a211d11bf/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e4d/5760891/35533f0ccb73/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e4d/5760891/70385df92963/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e4d/5760891/08aa29a59352/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e4d/5760891/9c16418c49bf/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e4d/5760891/3b26e93adb6d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e4d/5760891/e18cff5f87da/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e4d/5760891/f05a211d11bf/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e4d/5760891/35533f0ccb73/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e4d/5760891/70385df92963/gr7.jpg

相似文献

1
Development and validation of RP-HPLC and RP-UPLC methods for quantification of parathyroid hormones (1-34) in medicinal product formulated with meta-cresol.反相高效液相色谱法和反相超高效液相色谱法用于测定含间甲酚药用产品中甲状旁腺激素(1-34)的方法开发与验证
J Pharm Anal. 2012 Apr;2(2):136-142. doi: 10.1016/j.jpha.2011.12.001. Epub 2011 Dec 30.
2
Development and validation of RP-HPLC and RP-UPLC methods for quantification of erythropoietin formulated with human serum albumin.用于定量与人血清白蛋白配制的促红细胞生成素的反相高效液相色谱法和反相超高效液相色谱法的开发与验证
J Pharm Anal. 2012 Apr;2(2):160-165. doi: 10.1016/j.jpha.2011.11.006. Epub 2011 Nov 29.
3
Validation of a simple RP-HPLC method developed for the quantification of meta-cresol in parathyroid hormones formulation.用于定量甲状旁腺激素制剂中间甲酚的一种简单反相高效液相色谱法的验证。
Pharm Methods. 2011 Jul;2(3):203-8. doi: 10.4103/2229-4708.90366.
4
Rapid Development and Validation of Improved Reversed-Phase High-performance Liquid Chromatography Method for the Quantification of Mangiferin, a Polyphenol Xanthone Glycoside in .用于定量测定芒果苷(一种多酚氧杂蒽酮糖苷)的改进反相高效液相色谱法的快速开发与验证
Pharmacognosy Res. 2017 Apr-Jun;9(2):215-219. doi: 10.4103/0974-8490.204652.
5
Development and validation of a HPLC method for the determination of voriconazole in pharmaceutical formulation using an experimental design.采用实验设计法开发并验证一种用于测定药物制剂中伏立康唑的高效液相色谱法。
Talanta. 2007 Feb 28;71(3):1424-9. doi: 10.1016/j.talanta.2006.04.042. Epub 2007 Jan 10.
6
A simple, sensitive and rapid isocratic reversed-phase high-performance liquid chromatography method for determination and stability study of curcumin in pharmaceutical samples.一种用于测定药物样品中姜黄素并进行稳定性研究的简单、灵敏且快速的等度反相高效液相色谱法。
Avicenna J Phytomed. 2017 Sep-Oct;7(5):444-453.
7
Rapid determination of nitazoxanide in tablets using reversed-phase ultra-performance liquid chromatography (UPLC) and high-performance liquid chromatography.使用反相超高效液相色谱(UPLC)和高效液相色谱法快速测定片剂中的硝唑尼特。
Pharmazie. 2008 Jul;63(7):503-7.
8
Development and Validation of a Simple and Rapid UPLC-MS Assay for Valproic Acid and Its Comparison With Immunoassay and HPLC Methods.一种用于丙戊酸的简单快速超高效液相色谱-质谱分析法的开发与验证及其与免疫分析法和高效液相色谱法的比较
Ther Drug Monit. 2016 Apr;38(2):246-52. doi: 10.1097/FTD.0000000000000256.
9
Method Development and Validation for the Determination of Caffeine: An Alkaloid from by High-performance Liquid Chromatography Method.咖啡因(一种生物碱)测定的高效液相色谱法的方法开发与验证
Pharmacognosy Res. 2018 Jan-Mar;10(1):88-91. doi: 10.4103/pr.pr_79_17.
10
A New Rapid and Sensitive Stability-Indicating UPLC Assay Method for Tolterodine Tartrate: Application in Pharmaceuticals, Human Plasma and Urine Samples.一种用于酒石酸托特罗定的新型快速灵敏的稳定性指示超高效液相色谱测定方法:在药物制剂、人血浆和尿液样本中的应用。
Sci Pharm. 2012 Jan-Mar;80(1):101-14. doi: 10.3797/scipharm.1110-14. Epub 2011 Dec 5.

引用本文的文献

1
PTH Promotes Chondrogenesis of Fibrocartilage Stem Cells and Alleviates Temporomandibular Joint Osteoarthritis.甲状旁腺激素促进纤维软骨干细胞的软骨形成并减轻颞下颌关节骨关节炎。
Tissue Eng Regen Med. 2025 Jun 16. doi: 10.1007/s13770-025-00723-y.
2
Hydroxyapatite Incorporated with FeO@MCM-41 Core-Shell: A Promising Nanocomposite for Teriparatide Delivery in Bone Tissue Regeneration.负载FeO@MCM-41核壳结构的羟基磷灰石:一种用于骨组织再生中特立帕肽递送的有前景的纳米复合材料。
ACS Omega. 2023 Oct 26;8(44):41363-41373. doi: 10.1021/acsomega.3c04931. eCollection 2023 Nov 7.

本文引用的文献

1
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.甲状旁腺激素(1-34)对绝经后骨质疏松症女性骨折及骨密度的影响。
N Engl J Med. 2001 May 10;344(19):1434-41. doi: 10.1056/NEJM200105103441904.
2
Short-term increases in bone turnover markers predict parathyroid hormone-induced spinal bone mineral density gains in postmenopausal women with glucocorticoid-induced osteoporosis.骨转换标志物的短期升高可预测糖皮质激素诱导的骨质疏松绝经后女性中甲状旁腺激素诱导的脊柱骨密度增加。
Osteoporos Int. 2000;11(5):434-42. doi: 10.1007/s001980070111.
3
Crystal structure of human parathyroid hormone 1-34 at 0.9-A resolution.
人甲状旁腺激素1-34的晶体结构,分辨率为0.9埃。
J Biol Chem. 2000 Sep 1;275(35):27238-44. doi: 10.1074/jbc.M001134200.
4
Liquid chromatographic separation of some PTH-amino acids.一些甲状旁腺激素氨基酸的液相色谱分离
Biomed Chromatogr. 1998 Nov-Dec;12(6):322-5. doi: 10.1002/(SICI)1099-0801(199811/12)12:6<322::AID-BMC754>3.0.CO;2-0.
5
Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial.甲状旁腺激素治疗可逆转皮质类固醇诱导的骨质疏松症。一项随机对照临床试验的结果。
J Clin Invest. 1998 Oct 15;102(8):1627-33. doi: 10.1172/JCI3914.
6
Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis.甲状旁腺激素对接受雌激素治疗的绝经后骨质疏松症女性椎体骨量及骨折发生率影响的随机对照研究。
Lancet. 1997 Aug 23;350(9077):550-5. doi: 10.1016/S0140-6736(97)02342-8.
7
A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis.一项随机对照试验,比较周期性甲状旁腺激素与周期性甲状旁腺激素联合序贯降钙素对改善绝经后骨质疏松症女性骨量的疗效。
J Clin Endocrinol Metab. 1997 Feb;82(2):620-8. doi: 10.1210/jcem.82.2.3762.
8
Oxidation of recombinant human parathyroid hormone: effect of oxidized position on the biological activity.重组人甲状旁腺激素的氧化:氧化位置对生物活性的影响。
Pharm Res. 1995 Dec;12(12):2049-52. doi: 10.1023/a:1016281031373.
9
An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.在一项利用周期性甲状旁腺激素和降钙素治疗骨质疏松症的方案中,对几种骨形成和骨吸收生化标志物的评估。
J Clin Invest. 1993 Mar;91(3):1138-48. doi: 10.1172/JCI116273.
10
Nucleotide sequence of cloned cDNAs encoding human preproparathyroid hormone.编码人甲状旁腺激素原前体的克隆cDNA的核苷酸序列。
Proc Natl Acad Sci U S A. 1981 Dec;78(12):7365-9. doi: 10.1073/pnas.78.12.7365.